Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

GNAQ/GNA11 Mosaicism Causes Aberrant Calcium Signaling Susceptible to Targeted Therapeutics.

Zecchin D. et al, (2024), J Invest Dermatol, 144, 811 - 819.e4

Cinacalcet reverses short QT interval in Familial Hypocalciuric Hypercalcemia type 1

Cuny T. et al, (2023), The Journal of Clinical Endocrinology & Metabolism

Seizures in Sturge-Weber syndrome are associated with disrupted calcium metabolism

Zecchin D. et al, (2023), JOURNAL OF INVESTIGATIVE DERMATOLOGY, 143, S139 - S139

miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L2.

Kooblall KG. et al, (2022), Endocr Relat Cancer, 29, 557 - 568

Aberrant calcium signalling and systemic hypocalcaemia in GNAQ/11 mosaic diseases

Zecchin D. et al, (2022), BRITISH JOURNAL OF DERMATOLOGY, 187, 92 - 92

Long-term effectiveness of PTH(1-34) infusion therapy for autosomal dominant hypocalcaemia type 1

Sastre A. et al, (2021), HORMONE RESEARCH IN PAEDIATRICS, 94, 44 - 45

PTH Infusion for Seizures in Autosomal Dominant Hypocalcemia Type 1.

Sastre A. et al, (2021), N Engl J Med, 385, 189 - 191

Load More